(Q37816963)

23 August 2017

1 reference

title

Effects of polyunsaturated fatty acid consumption in diabetic nephropathy (English)

1 reference

23 August 2017

0 references

Haim Shapiro

1

1 reference

23 August 2017

Miryam Theilla

series ordinal

2

1 reference

23 August 2017

Joelle Attal-Singer

series ordinal

3

1 reference

23 August 2017

Pierre Singer

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

7 December 2010

1 reference

Nature Reviews Nephrology

23 August 2017

published in

1 reference

23 August 2017

volume

7

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

110-121

1 reference

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Immunomodulation by omega-3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Review of the effects of omega-3 supplementation in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Physiologic and pathophysiologic roles of lipid mediators in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Emerging roles for eicosanoids in renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Kidney CYP450 enzymes: biological actions beyond drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Arachidonic acid cytochrome P450 epoxygenase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Resolvin D series and protectin D1 mitigate acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Alpha-linolenic acid metabolism in men and women: nutritional and biological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Decreased activity of desaturase 5 in association with obesity and insulin resistance aggravates declining long-chain n-3 fatty acid status in Cree undergoing dietary transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Omega-3 fatty acid rich diet prevents diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Signaling pathways modulated by fish oil in salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Does fish oil lower blood pressure? A meta-analysis of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Dietary intake of eicosapentaenoic and docosahexaenoic acid and diabetic nephropathy: cohort analysis of the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Polyunsaturated fatty acid consumption may play a role in the onset and regression of microalbuminuria in well-controlled type 1 and type 2 diabetic people: a 7-year, prospective, population-based, observational multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

The effects of Italian Mediterranean organic diet (IMOD) on health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Cross-sectional Association Between Fish Consumption and Albuminuria: The European Prospective Investigation of Cancer–Norfolk Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

N-3 fatty acids: food or supplements?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Docosahexaenoic acid and eicosapentaenoic acid, but not alpha-linolenic acid, suppress deoxynivalenol-induced experimental IgA nephropathy in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Studies on the impact of dietary fat composition on proteinuria in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Life span is shortened in BHE/cdb rats fed a diet containing 9% menhaden oil and 1% corn oil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Oxidized omega-3 fatty acids inhibit pro-inflammatory responses in glomerular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Effect of insulin treatment on fatty acids of plasma and erythrocyte membrane lipids in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Fish Oil in Diabetic Nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.156

The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21135888

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nephropathy in diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21135888

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2010.156

1 reference

23 August 2017

1 reference